Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion

被引:21
作者
Cavazzini, Francesco [1 ]
Lista, Enrico [1 ]
Quaglia, Francesca Maria [1 ]
Formigaro, Luca [1 ]
Cavallari, Maurizio [1 ]
Martinelli, Sara [1 ]
Rigolin, Gian Matteo [1 ]
Foa, Robin [2 ]
Cuneo, Antonio [1 ]
机构
[1] Univ Ferrara, Dept Med Sci, Sect Hematol, Ferrara, Italy
[2] Univ Roma La Sapienza, Div Hematol, Rome, Italy
关键词
INHIBITOR;
D O I
10.3109/10428194.2016.1154955
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2685 / 2688
页数:4
相关论文
共 15 条
  • [1] Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia - response to Rider etal
    Danilov, Alexey V.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (02) : 327 - 328
  • [2] Dearden Claire, 2008, Hematology Am Soc Hematol Educ Program, P450, DOI 10.1182/asheducation-2008.1.450
  • [3] Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
    Dubovsky, Jason A.
    Beckwith, Kyle A.
    Natarajan, Gayathri
    Woyach, Jennifer A.
    Jaglowski, Samantha
    Zhong, Yiming
    Hessler, Joshua D.
    Liu, Ta-Ming
    Chang, Betty Y.
    Larkin, Karilyn M.
    Stefanovski, Matthew R.
    Chappell, Danielle L.
    Frissora, Frank W.
    Smith, Lisa L.
    Smucker, Kelly A.
    Flynn, Joseph M.
    Jones, Jeffrey A.
    Andritsos, Leslie A.
    Maddocks, Kami
    Lehman, Amy M.
    Furman, Richard
    Sharman, Jeff
    Mishra, Anjali
    Caligiuri, Michael A.
    Satoskar, Abhay R.
    Buggy, Joseph J.
    Muthusamy, Natarajan
    Johnson, Amy J.
    Byrd, John C.
    [J]. BLOOD, 2013, 122 (15) : 2539 - 2549
  • [4] Chronic lymphocytic leukemia cells bind and present the erythrocyte protein band 3:: Possible role as initiators of autoimmune hemolytic anemia
    Galletti, Jeremias
    Canones, Cristian
    Morande, Pablo
    Borge, Mercedes
    Oppezzo, Pablo
    Geffner, Jorge
    Bezares, Raimundo
    Gamberale, Romina
    Giordano, Mirta
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 181 (05) : 3674 - 3683
  • [5] Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
    Hallek, Michael
    Cheson, Bruce D.
    Catovsky, Daniel
    Caligaris-Cappio, Federico
    Dighiero, Guillaume
    Doehner, Hartmut
    Hillmen, Peter
    Keating, Michael J.
    Montserrat, Emili
    Rai, Kanti R.
    Kipps, Thomas J.
    [J]. BLOOD, 2008, 111 (12) : 5446 - 5456
  • [6] Chronic lymphocytic leukemia and autoimmunity: a systematic review
    Hodgson, Kate
    Ferrer, Gerardo
    Montserrat, Emili
    Moreno, Carol
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (05): : 752 - 761
  • [7] The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
    Honigberg, Lee A.
    Smith, Ashley M.
    Sirisawad, Mint
    Verner, Erik
    Loury, David
    Chang, Betty
    Li, Shyr
    Pan, Zhengying
    Thamm, Douglas H.
    Miller, Richard A.
    Buggy, Joseph J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (29) : 13075 - 13080
  • [8] Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity
    Kohrt, Holbrook E.
    Sagiv-Barfi, Idit
    Rafiq, Sarwish
    Herman, Sarah E. M.
    Butchar, Jonathon P.
    Cheney, Carolyn
    Zhang, Xiaoli
    Buggy, Joseph J.
    Muthusamy, Natarajan
    Levy, Ronald
    Johnson, Amy J.
    Byrd, John C.
    [J]. BLOOD, 2014, 123 (12) : 1957 - 1960
  • [9] Ibrutinib is an effective treatment of autoimmune haemolytic anaemia in chronic lymphocytic leukaemia
    Manda, Sudhir
    Dunbar, Nancy
    Marx-Wood, Cynthia R.
    Danilov, Alexey V.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (05) : 734 - 736
  • [10] Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features
    Mauro, FR
    Foa, R
    Cerretti, R
    Giannarelli, D
    Coluzzi, S
    Mandelli, F
    Girelli, G
    [J]. BLOOD, 2000, 95 (09) : 2786 - 2792